Longitudinal synaptic loss versus tau Braak staging in amnestic mild cognitive impairment.

Autor: Vanderlinden G; Nuclear Medicine and Molecular Imaging, Imaging and Pathology, KU Leuven, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, Leuven, Belgium., Koole M; Nuclear Medicine and Molecular Imaging, Imaging and Pathology, KU Leuven, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, Leuven, Belgium., Michiels L; Leuven Brain Institute, KU Leuven, Leuven, Belgium.; Department of Neurology, University Hospitals UZ Leuven, Leuven, Belgium.; VIB, Center for Brain & Disease Research, Laboratory of Neurobiology, Leuven, Belgium.; Department of Neurosciences, KU Leuven, Leuven, Belgium., Lemmens R; Leuven Brain Institute, KU Leuven, Leuven, Belgium.; Department of Neurology, University Hospitals UZ Leuven, Leuven, Belgium.; VIB, Center for Brain & Disease Research, Laboratory of Neurobiology, Leuven, Belgium.; Department of Neurosciences, KU Leuven, Leuven, Belgium., Vandenbulcke M; Leuven Brain Institute, KU Leuven, Leuven, Belgium.; Department of Geriatric Psychiatry, University Hospitals UZ Leuven, Leuven, Belgium.; Neuropsychiatry, Research Group Psychiatry, KU Leuven, Leuven, Belgium., Van Laere K; Nuclear Medicine and Molecular Imaging, Imaging and Pathology, KU Leuven, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, Leuven, Belgium.; Division of Nuclear Medicine, University Hospitals UZ Leuven, Leuven, Belgium.
Jazyk: angličtina
Zdroj: Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2024 Dec 28. Date of Electronic Publication: 2024 Dec 28.
DOI: 10.1002/alz.14412
Abstrakt: Introduction: The longitudinal progression of synaptic loss in Alzheimer's disease (AD) and how it is affected by tau pathology remains poorly understood.
Methods: Thirty patients with amnestic mild cognitive impairment (aMCI) and 26 healthy controls underwent cognitive evaluations and tau, synaptic vesicle protein 2A (SV2A), and amyloid positron emission tomography. Twenty-one aMCI underwent 2-year follow-up (FU) investigations.
Results: Tau levels in aMCI increased longitudinally in Braak regions III through VI but not in Braak regions I and II. SV2A decreased longitudinally in all Braak regions in aMCI. Baseline tau was negatively associated with longitudinal SV2A loss in early Braak regions and with SV2A at FU across regions. Baseline tau and longitudinal change in SV2A were associated with longitudinal cognitive decline.
Discussion: Tau accumulation reaches a plateau in early Braak regions already in the aMCI stage of AD. In early Braak regions, the association between baseline tau and longitudinal SV2A loss might reflect synaptic dysfunction caused by tau pathology.
Highlights: Tau accumulation reached a plateau in early Braak regions in amnestic mild cognitive impairment (aMCI) patients. aMCI patients show widespread longitudinal decrease in synaptic vesicle protein 2A (SV2A) over 2 years. Baseline tau was predictive for longitudinal SV2A loss. The tau-SV2A relation showed individual variability and was negative across patients. Baseline tau and longitudinal SV2A change were associated with change in cognition.
(© 2024 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.)
Databáze: MEDLINE
Externí odkaz: